Medigen Vaccine (Taiwan) Analysis
| 6547 Stock | TWD 38.90 0.25 0.64% |
Medigen Vaccine Biologics is overvalued with Real Value of 35.01 and Hype Value of 38.9. The main objective of Medigen Vaccine stock analysis is to determine its intrinsic value, which is an estimate of what Medigen Vaccine Biologics is worth, separate from its market price. There are two main types of Medigen Vaccine's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Medigen Vaccine's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Medigen Vaccine's stock to identify patterns and trends that may indicate its future price movements.
The Medigen Vaccine stock is traded in Taiwan on Taiwan OTC Exchange, with the market opening at 09:00:00 and closing at 13:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Taiwan. Medigen Vaccine is usually not traded on No Trading . Market opens only for Clearing & Settlement, Mid - autumn / Moon Festival, No Trading . Market opens only for Clearing & Settlement 2, Adjusted Holiday / Chinese New Year 's Eve, Chinese New Year 's Eve, Chinese New Year, Dragon Boat Festival, National Day of the Republic of China, Chinese New Year 2, Chinese New Year 3, Adjusted Holiday 1, Adjusted Holiday 2. Medigen Stock trading window is adjusted to Asia/Taipei timezone.
Medigen |
Medigen Stock Analysis Notes
About 28.0% of the company shares are owned by insiders or employees . The book value of Medigen Vaccine was presently reported as 17.52. The company had not issued any dividends in recent years. Medigen Vaccine Biologics had 1482:1000 split on the 3rd of August 2022. Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp. MEDIGEN VACCINE operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. For more info on Medigen Vaccine Biologics please contact the company at 886 2 7745 0830 or go to https://www.medigenvac.com.Medigen Vaccine Biologics Investment Alerts
| Medigen Vaccine generated a negative expected return over the last 90 days | |
| About 28.0% of the company shares are owned by insiders or employees |
Medigen Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 23.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medigen Vaccine's market, we take the total number of its shares issued and multiply it by Medigen Vaccine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Medigen Profitablity
Medigen Vaccine's profitability indicators refer to fundamental financial ratios that showcase Medigen Vaccine's ability to generate income relative to its revenue or operating costs. If, let's say, Medigen Vaccine is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Medigen Vaccine's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Medigen Vaccine's profitability requires more research than a typical breakdown of Medigen Vaccine's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.13 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09. Technical Drivers
As of the 29th of November, Medigen Vaccine secures the Mean Deviation of 1.15, standard deviation of 1.46, and Risk Adjusted Performance of (0.16). Medigen Vaccine Biologics technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Medigen Vaccine Biologics coefficient of variation, variance, and the relationship between the mean deviation and standard deviation to decide if Medigen Vaccine Biologics is priced some-what accurately, providing market reflects its recent price of 38.9 per share.Medigen Vaccine Biologics Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medigen Vaccine middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medigen Vaccine Biologics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Medigen Vaccine Outstanding Bonds
Medigen Vaccine issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medigen Vaccine Biologics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medigen bonds can be classified according to their maturity, which is the date when Medigen Vaccine Biologics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Medigen Vaccine Predictive Daily Indicators
Medigen Vaccine intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medigen Vaccine stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 18250.98 | |||
| Daily Balance Of Power | (0.22) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 38.78 | |||
| Day Typical Price | 38.82 | |||
| Period Momentum Indicator | (0.25) |
Medigen Vaccine Forecast Models
Medigen Vaccine's time-series forecasting models are one of many Medigen Vaccine's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medigen Vaccine's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Medigen Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Medigen Vaccine prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medigen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Medigen Vaccine. By using and applying Medigen Stock analysis, traders can create a robust methodology for identifying Medigen entry and exit points for their positions.
Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp. MEDIGEN VACCINE operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Medigen Vaccine to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Additional Tools for Medigen Stock Analysis
When running Medigen Vaccine's price analysis, check to measure Medigen Vaccine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Vaccine is operating at the current time. Most of Medigen Vaccine's value examination focuses on studying past and present price action to predict the probability of Medigen Vaccine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Vaccine's price. Additionally, you may evaluate how the addition of Medigen Vaccine to your portfolios can decrease your overall portfolio volatility.